In the afternoon of May 2, 2019, Dr. Ming-Wei Wang, Director of the National Center for Drug Screening/Chinese National Compound Library and Dean of School of Pharmacy, Fudan University, met with Mr. Jacob Thaysen, President of Life Sciences & Applied Markets Group, Agilent Technologies, Inc. and Madam Ying Chow, Great China Sales Development & Strategic Program Manager of Agilent Technologies (China) Co., Ltd., at Agilent’s headquarters located in Santa Clara, California (U.S.A.). The two parties briefed each other of their respective initiatives in cell therapy and expressed a common desire to develop multilateral collaboration mechanisms. Dr. Wang also interacted with Dr. Kelly M. Kroeger (Section Manager, Molecular & Cellular Biology, Agilent Research Laboratories), several of her associates and Dr. Maryann L. Shen (Applications & Solutions Marketing Director, Mass Spectrometry Division) relative to the development and promotion of single cell and mass spectrometry analysis technologies. They agreed on the follow-up action plan.